Compare CLGN & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLGN | LRE |
|---|---|---|
| Founded | 2004 | 2001 |
| Country | Israel | Japan |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 17.2M |
| IPO Year | 2015 | 2022 |
| Metric | CLGN | LRE |
|---|---|---|
| Price | $0.63 | $1.36 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 99.5K | 17.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,596.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.50 | $1.00 |
| 52 Week High | $4.98 | $2.86 |
| Indicator | CLGN | LRE |
|---|---|---|
| Relative Strength Index (RSI) | 34.59 | 50.52 |
| Support Level | $0.50 | $1.34 |
| Resistance Level | $1.60 | $1.57 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 63.40 | 41.18 |
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.